This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: University of Colorado, Suvica, Inc.. Active years: 2010-2019.
Company Filing History:
3 out of 1,443 
2 out of 2 Years Active: 2010-2019
Title: The Innovative Contributions of Tin Tin Su
Introduction
Tin Tin Su is a notable inventor based in Boulder, CO (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment. With a total of 3 patents, his work has the potential to impact therapeutic approaches in oncology.
Latest Patents
Among his latest patents, Tin Tin Su has developed bouvardin derivatives and their therapeutic uses. The present invention focuses on bouvardin analogs and related compounds aimed at treating disorders, including cancer. These compounds are designed to inhibit translation elongation at the ribosome and can be used in combination with radiation therapy or known chemotherapeutic compositions. This innovative approach highlights the potential of bouvardin analogs in enhancing cancer treatment efficacy.
Career Highlights
Tin Tin Su has worked with reputable organizations, including the University of Colorado and Suvica, Inc. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Mara N Gladstone and Gan Zhang. Their collaborative efforts have likely enriched the research environment and fostered innovative solutions in their respective fields.
Conclusion
Tin Tin Su's contributions to the field of pharmaceuticals, particularly through his patents on bouvardin derivatives, demonstrate his commitment to advancing cancer treatment. His work continues to inspire future innovations in medical research.